ClinicalTrials.gg
Drug

Mifepristone clinical trials

Also written Mifeprex, RU-486, Korlym and Mifegyne.

studies test it
149
open now
10
in phase 3
33
first study started
1992

How each study uses Mifepristone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Mifepristone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Sept 2000 · MIFEPREX · NDA 020687 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mifepristone
105
CORLUX
4
mifepristone 200 mg
3
Danco
2
Mifepristone 1200 mg daily
2

Brand

Mifeprex
19
Korlym
9

Development codes

RU-486
15
RU-38486
3

Other names

Mifegyne
9

In one entry with another drug

Given together, or one or the other

Mifepristone and misoprostol
5
Mifepristone, misoprostol
4
Mifepristone + Misoprostol
3
mifepristone+misoprostol
3

Studies by the year they started

147 studies that test it; most in 2013 (12); 1 more planned to start later

Studies that test Mifepristone, by start year
YearStudies
19921
19981
20011
20021
20035
20048
20058
20063
20079
20089
200910
20106
20116
20127
201312
20145
20154
20167
201711
20184
20192
20205
20217
20224
20234
20244
20252
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
20
Phase 2
48
Phase 3
33
Phase 4
34
No phase
24

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 126

Gynuity Health Projects (26) · Corcept Therapeutics (18) · Stanford University (9) · University of Chicago (5) · Boston University (4) · Washington University School of Medicine (3) · Karolinska Institutet (3) · University of Pittsburgh (3)

Often tested with

Tested in the same studies.

Misoprostol (32) · Etanercept (2) · Cycloserine (2) · Oxytocin (2) · Letrozole (2) · Progesterone (1) · Spironolactone (1) · Dexamethasone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 1 in phase 3

Studies that test Mifepristone, phase 3 first.

Studies

Open first, then newest update. How each study uses Mifepristone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 149

See all 149 studies that test Mifepristone →

Given beside what is tested · 4 — Mifepristone is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Mifepristone

Codes

What other systems call Mifepristone · ClinicalTrials.gg INT008488

  • MeSH (NLM) D015735MifepristoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 320T6RNW1FMIFEPRISTONEConfirmed FDA, NLM, Wikidata
  • RxNorm 6964Confirmed FDA, Wikidata
  • Wikidata Q411240mifepristoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C655MifepristoneOne source FDA
  • DrugBank DB00834One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.